352 related articles for article (PubMed ID: 7687062)
1. Two nonpeptide tachykinin antagonists act through epitopes on corresponding segments of the NK1 and NK2 receptors.
Gether U; Yokota Y; Emonds-Alt X; Brelière JC; Lowe JA; Snider RM; Nakanishi S; Schwartz TW
Proc Natl Acad Sci U S A; 1993 Jul; 90(13):6194-8. PubMed ID: 7687062
[TBL] [Abstract][Full Text] [Related]
2. The species selectivity of chemically distinct tachykinin nonpeptide antagonists is dependent on common divergent residues of the rat and human neurokinin-1 receptors.
Jensen CJ; Gerard NP; Schwartz TW; Gether U
Mol Pharmacol; 1994 Feb; 45(2):294-9. PubMed ID: 7509441
[TBL] [Abstract][Full Text] [Related]
3. Identification of both NK1 and NK2 receptors in guinea-pig airways.
McKee KT; Millar L; Rodger IW; Metters KM
Br J Pharmacol; 1993 Oct; 110(2):693-700. PubMed ID: 7694756
[TBL] [Abstract][Full Text] [Related]
4. Capsaicin increases airflow resistance in guinea pigs in vivo by activating both NK2 and NK1 tachykinin receptors.
Bertrand C; Nadel JA; Graf PD; Geppetti P
Am Rev Respir Dis; 1993 Oct; 148(4 Pt 1):909-14. PubMed ID: 7692775
[TBL] [Abstract][Full Text] [Related]
5. SR 48968 specifically depresses neurokinin A- vs. substance P-induced hyperalgesia in a nociceptive withdrawal reflex.
Yashpal K; Hui-Chan CW; Henry JL
Eur J Pharmacol; 1996 Jul; 308(1):41-8. PubMed ID: 8836630
[TBL] [Abstract][Full Text] [Related]
6. Effects on the isolated human bronchus of SR 48968, a potent and selective nonpeptide antagonist of the neurokinin A (NK2) receptors.
Advenier C; Naline E; Toty L; Bakdach H; Emonds-Alt X; Vilain P; Brelière JC; Le Fur G
Am Rev Respir Dis; 1992 Nov; 146(5 Pt 1):1177-81. PubMed ID: 1332556
[TBL] [Abstract][Full Text] [Related]
7. Use of non-peptide tachykinin receptor antagonists to substantiate the involvement of NK1 and NK2 receptors in a spinal nociceptive reflex in the rat.
Picard P; Boucher S; Regoli D; Gitter BD; Howbert JJ; Couture R
Eur J Pharmacol; 1993 Mar; 232(2-3):255-61. PubMed ID: 7682180
[TBL] [Abstract][Full Text] [Related]
8. Evidence for a common molecular mode of action for chemically distinct nonpeptide antagonists at the neurokinin-1 (substance P) receptor.
Gether U; Emonds-Alt X; Brelière JC; Fujii T; Hagiwara D; Pradier L; Garret C; Johansen TE; Schwartz TW
Mol Pharmacol; 1994 Mar; 45(3):500-8. PubMed ID: 8145735
[TBL] [Abstract][Full Text] [Related]
9. Pharmacology of an original and selective nonpeptide antagonist ligand for the human tachykinin NK2 receptor.
Meini S; Catalani C; Bellucci F; Cucchi P; Giuliani S; Zappitelli S; Rotondaro L; Pasqui F; Guidi A; Altamura M; Giolitti A; Maggi CA
Eur J Pharmacol; 2005 Jun; 516(2):104-11. PubMed ID: 15925360
[TBL] [Abstract][Full Text] [Related]
10. Effects of central administration of tachykinin receptor agonists and antagonists on plus-maze behavior in mice.
Teixeira RM; Santos AR; Ribeiro SJ; Calixto JB; Rae GA; De Lima TC
Eur J Pharmacol; 1996 Sep; 311(1):7-14. PubMed ID: 8884230
[TBL] [Abstract][Full Text] [Related]
11. Different binding epitopes on the NK1 receptor for substance P and non-peptide antagonist.
Gether U; Johansen TE; Snider RM; Lowe JA; Nakanishi S; Schwartz TW
Nature; 1993 Mar; 362(6418):345-8. PubMed ID: 7681152
[TBL] [Abstract][Full Text] [Related]
12. Chimeric NK1 (substance P)/NK3 (neurokinin B) receptors. Identification of domains determining the binding specificity of tachykinin agonists.
Gether U; Johansen TE; Schwartz TW
J Biol Chem; 1993 Apr; 268(11):7893-8. PubMed ID: 7681831
[TBL] [Abstract][Full Text] [Related]
13. Tachykinins mediate contraction of the human lower esophageal sphincter in vitro via activation of NK2 receptors.
Huber O; Bertrand C; Bunnett NW; Pellegrini CA; Nadel JA; Nakazato P; Debas HT; Geppetti P
Eur J Pharmacol; 1993 Aug; 239(1-3):103-9. PubMed ID: 8223885
[TBL] [Abstract][Full Text] [Related]
14. Receptors mediating tachykinin-evoked depolarisations of neurons in the neonatal rat spinal cord.
Fox AJ; Naeem S; Patel IA; Walpole C; Urbán L
Acta Biol Hung; 1996; 47(1-4):129-44. PubMed ID: 9123986
[TBL] [Abstract][Full Text] [Related]
15. NK1 and NK2 receptors mediate tachykinin and resiniferatoxin-induced bronchospasm in guinea pigs.
Foulon DM; Champion E; Masson P; Rodger IW; Jones TR
Am Rev Respir Dis; 1993 Oct; 148(4 Pt 1):915-21. PubMed ID: 7692776
[TBL] [Abstract][Full Text] [Related]
16. Effect of tachykinin receptor inhibition in the brain on cardiovascular and behavioral responses to stress.
Culman J; Klee S; Ohlendorf C; Unger T
J Pharmacol Exp Ther; 1997 Jan; 280(1):238-46. PubMed ID: 8996202
[TBL] [Abstract][Full Text] [Related]
17. Influence of (+/-)-CP-96,345 and SR 48968 on electrical field stimulation of the isolated guinea-pig main bronchus.
Martin CA; Naline E; Emonds-Alt X; Advenier C
Eur J Pharmacol; 1992 Dec; 224(2-3):137-43. PubMed ID: 1334836
[TBL] [Abstract][Full Text] [Related]
18. Differential blockade by tachykinin NK1 and NK2 receptor antagonists of bronchoconstriction induced by direct-acting agonists and the indirect-acting mimetics capsaicin, serotonin and 2-methyl-serotonin in the anesthetized guinea pig.
Buckner CK; Liberati N; Dea D; Lengel D; Stinson-Fisher C; Campbell J; Miller S; Shenvi A; Krell RD
J Pharmacol Exp Ther; 1993 Dec; 267(3):1168-75. PubMed ID: 8263778
[TBL] [Abstract][Full Text] [Related]
19. Contractile effect of tachykinins on Suncus murinus (house musk shrew) isolated ileum.
Cheng FH; Chan SW; Rudd JA
Neuropeptides; 2008; 42(5-6):671-9. PubMed ID: 18582934
[TBL] [Abstract][Full Text] [Related]
20. Radioiodinated substance P, neurokinin A, and eledoisin bind predominantly in NK1 receptors in guinea pig lung.
Geraghty DP; Mussap CJ; Burcher E
Mol Pharmacol; 1992 Jan; 41(1):147-53. PubMed ID: 1370705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
